281 related articles for article (PubMed ID: 34873015)
1. Dermatomyositis: Muscle Pathology According to Antibody Subtypes.
Tanboon J; Inoue M; Saito Y; Tachimori H; Hayashi S; Noguchi S; Okiyama N; Fujimoto M; Nishino I
Neurology; 2022 Feb; 98(7):e739-e749. PubMed ID: 34873015
[TBL] [Abstract][Full Text] [Related]
2. Pathologic Features of Anti-Mi-2 Dermatomyositis.
Tanboon J; Inoue M; Hirakawa S; Tachimori H; Hayashi S; Noguchi S; Suzuki S; Okiyama N; Fujimoto M; Nishino I
Neurology; 2021 Jan; 96(3):e448-e459. PubMed ID: 33277422
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic potential of sarcoplasmic myxovirus resistance protein A expression in subsets of dermatomyositis.
Uruha A; Allenbach Y; Charuel JL; Musset L; Aussy A; Boyer O; Mariampillai K; Landon-Cardinal O; Rasmussen C; Bolko L; Maisonobe T; Leonard-Louis S; Suzuki S; Nishino I; Stenzel W; Benveniste O
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):513-522. PubMed ID: 30267437
[TBL] [Abstract][Full Text] [Related]
4. Perimysial microarteriopathy in dermatomyositis with anti-nuclear matrix protein-2 antibodies.
Liu Y; Zheng Y; Gang Q; Xie Z; Jin Y; Zhang X; Deng X; Hao H; Gao F; Zhang Z; Xiong H; Zhang W; Wang Z; Yuan Y
Eur J Neurol; 2020 Mar; 27(3):514-521. PubMed ID: 31571350
[TBL] [Abstract][Full Text] [Related]
5. Anti-Jo-1 antibody-positive patients show a characteristic necrotizing perifascicular myositis.
Mescam-Mancini L; Allenbach Y; Hervier B; Devilliers H; Mariampillay K; Dubourg O; Maisonobe T; Gherardi R; Mezin P; Preusse C; Stenzel W; Benveniste O
Brain; 2015 Sep; 138(Pt 9):2485-92. PubMed ID: 26198592
[TBL] [Abstract][Full Text] [Related]
6. Association of Dermatomyositis Sine Dermatitis With Anti-Nuclear Matrix Protein 2 Autoantibodies.
Inoue M; Tanboon J; Hirakawa S; Komaki H; Fukushima T; Awano H; Tajima T; Yamazaki K; Hayashi R; Mori T; Shibuya K; Yamanoi T; Yoshimura H; Ogawa T; Katayama A; Sugai F; Nakayama Y; Yamaguchi S; Hayashi S; Noguchi S; Tachimori H; Okiyama N; Fujimoto M; Nishino I
JAMA Neurol; 2020 Jul; 77(7):872-877. PubMed ID: 32310254
[TBL] [Abstract][Full Text] [Related]
7. Muscle pathology of antisynthetase syndrome according to antibody subtypes.
Tanboon J; Inoue M; Hirakawa S; Tachimori H; Hayashi S; Noguchi S; Okiyama N; Fujimoto M; Suzuki S; Nishino I
Brain Pathol; 2023 Jul; 33(4):e13155. PubMed ID: 36882048
[TBL] [Abstract][Full Text] [Related]
8. Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features.
Troyanov Y; Targoff IN; Payette MP; Raynauld JP; Chartier S; Goulet JR; Bourré-Tessier J; Rich E; Grodzicky T; Fritzler MJ; Joyal F; Koenig M; Senécal JL
Medicine (Baltimore); 2014 Nov; 93(24):318-332. PubMed ID: 25500701
[TBL] [Abstract][Full Text] [Related]
9. Sarcoplasmic MxA expression: A valuable marker of dermatomyositis.
Uruha A; Nishikawa A; Tsuburaya RS; Hamanaka K; Kuwana M; Watanabe Y; Suzuki S; Suzuki N; Nishino I
Neurology; 2017 Jan; 88(5):493-500. PubMed ID: 28039312
[TBL] [Abstract][Full Text] [Related]
10. Update on dermatomyositis.
Tanboon J; Nishino I
Curr Opin Neurol; 2022 Oct; 35(5):611-621. PubMed ID: 35942671
[TBL] [Abstract][Full Text] [Related]
11. Distinct tissue injury patterns in juvenile dermatomyositis auto-antibody subgroups.
Nguyen M; Do V; Yell PC; Jo C; Liu J; Burns DK; Wright T; Cai C
Acta Neuropathol Commun; 2020 Aug; 8(1):125. PubMed ID: 32758284
[TBL] [Abstract][Full Text] [Related]
12. Sarcoplasmic Myxovirus Resistance Protein A: A Study of Expression in Idiopathic Inflammatory Myopathy.
Waisayarat J; Wongsuwan P; Tuntiseranee K; Waisayarat P; Dejthevaporn C; Khongkhatithum C; Soponkanaporn S
J Inflamm Res; 2023; 16():5417-5426. PubMed ID: 38026261
[TBL] [Abstract][Full Text] [Related]
13. Myopathy with anti-Jo-1 antibodies: pathology in perimysium and neighbouring muscle fibres.
Mozaffar T; Pestronk A
J Neurol Neurosurg Psychiatry; 2000 Apr; 68(4):472-8. PubMed ID: 10727483
[TBL] [Abstract][Full Text] [Related]
14. Expression of myxovirus-resistance protein A: a possible marker of muscle disease activity and autoantibody specificities in juvenile dermatomyositis.
Soponkanaporn S; Deakin CT; Schutz PW; Marshall LR; Yasin SA; Johnson CM; Sag E; Tansley SL; McHugh NJ; Wedderburn LR; Jacques TS
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):410-420. PubMed ID: 29770465
[TBL] [Abstract][Full Text] [Related]
15. The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies.
Xu Q; Li QX; Bi FF; Duan HQ; Luo YB; Yang H
Clin Rheumatol; 2021 Feb; 40(2):613-624. PubMed ID: 32671659
[TBL] [Abstract][Full Text] [Related]
16. Acquired immune and inflammatory myopathies: pathologic classification.
Pestronk A
Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
[TBL] [Abstract][Full Text] [Related]
17. Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies.
Mariampillai K; Granger B; Amelin D; Guiguet M; Hachulla E; Maurier F; Meyer A; Tohmé A; Charuel JL; Musset L; Allenbach Y; Benveniste O
JAMA Neurol; 2018 Dec; 75(12):1528-1537. PubMed ID: 30208379
[TBL] [Abstract][Full Text] [Related]
18. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
Merlonghi G; Antonini G; Garibaldi M
Autoimmun Rev; 2022 Feb; 21(2):102993. PubMed ID: 34798316
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and myopathological features of Jo-1 syndrome].
Meng LC; Li Y; Zhang W; Hao HJ; Gao F; Yuan Y
Zhonghua Yi Xue Za Zhi; 2016 Aug; 96(29):2352-5. PubMed ID: 27524195
[TBL] [Abstract][Full Text] [Related]
20. RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.
Suárez-Calvet X; Gallardo E; Pinal-Fernandez I; De Luna N; Lleixà C; Díaz-Manera J; Rojas-García R; Castellví I; Martínez MA; Grau JM; Selva-O'Callaghan A; Illa I
Arthritis Res Ther; 2017 Jul; 19(1):174. PubMed ID: 28738907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
